第一单位：
Frederick National Laboratory for Cancer Research, Vaccine, Immunity, and Cancer Directorate, Frederick, MD, United States.
作者：
Yurong,Song [1]
;
Travis D,Kerr [1]
;
Chelsea,Sanders [2]
;
Lisheng,Dai [1]
;
Shaneen S,Baxter [1]
;
Brandon,Somerville [1]
;
Ryan N,Baugher [3]
;
Stephanie D,Mellott [3]
;
Todd B,Young [3]
;
Heidi E,Lawhorn [3]
;
Teri M,Plona [3]
;
Bingfang,Xu [4]
;
Lei,Wei [5]
;
Qiang,Hu [5]
;
Song,Liu [5]
;
Alan,Hutson [5]
;
Baktiar,Karim [6]
;
Sandra,Burkett [7]
;
Simone,Difilippantonio [2]
;
Ligia,Pinto [1]
;
Johannes,Gebert [8]
;
Matthias,Kloor [8]
;
Steven M,Lipkin [9]
;
Shizuko,Sei [10]
;
Robert H,Shoemaker [10]
作者单位：
Frederick National Laboratory for Cancer Research, Vaccine, Immunity, and Cancer Directorate, Frederick, MD, United States.
[1]
Frederick National Laboratory for Cancer Research, Laboratory Animal Sciences Program, Frederick, MD, United States.
[2]
Frederick National Laboratory for Cancer Research, Clinical Laboratory Improvement Amendments (CLIA) Molecular Diagnostics Laboratory, Frederick, MD, United States.
[3]
Frederick National Laboratory for Cancer Research, Genomics Laboratory, Frederick, MD, United States.
[4]
Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States.
[5]
Molecular Histopathology Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.
[6]
Molecular Cytogenetics Core Facility, National Cancer Institute, Frederick, MD, United States.
[7]
Department of Applied Tumor Biology, Institute of Pathology, University of Heidelberg, Heidelberg, Germany.
[8]
Department of Medicine, Weill Cornell Medical College, Cornell University, New York, NY, United States.
[9]
Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, United States.
[10]
DOI
10.3389/fonc.2023.1223915
PMID
37746286
发布时间
2023-09-26
换一批
